Bacterial-responsive nanocarriers are designed to release antibacterial agents only when there are specific infection cues present. This selective activation ensures that the drug is precisely released at the infection site, avoiding premature or indiscriminate release, thereby enhancing efficacy. These advanced materials are intended to improve the penetration of drugs into biofilms, outperforming traditional therapies, and help prevent the emergence of antibiotic resistance. This research was published in the journal Advanced Materials under the title "Bacteria-Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy".
References: 
DOI: 10.1002/adma.20251035